Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience

OC-0565: SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC

(2015) J. Nyman et al.   RADIOTHERAPY AND ONCOLOGY

Dose–response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance

(2014) Larry Kestin et al.   RADIOTHERAPY AND ONCOLOGY

High-risk CT features for detection of local recurrence after stereotactic ablative radiotherapy for lung cancer

(2013) Kitty Huang et al.   RADIOTHERAPY AND ONCOLOGY

Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer

(2012) Yukinori Matsuo et al.   Journal of Thoracic Oncology

Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?

(2012) Matthias Guckenberger et al.   Journal of Thoracic Oncology

Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer

(2011) Yuta Shibamoto et al.   CANCER

Stereotactic radiotherapy of histologically proven inoperable stage I non-small cell lung cancer: Patterns of failure

(2011) Nicolaus Andratschke et al.   RADIOTHERAPY AND ONCOLOGY

Prognostic Factors in Stereotactic Body Radiotherapy for Non–Small-Cell Lung Cancer

(2010) Yukinori Matsuo et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer

(2010) Robert Timmerman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination

(2009) Tetsuya Inoue et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II Study

(2009) Achilles J. Fakiris et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

(2009) Pia Baumann et al.   JOURNAL OF CLINICAL ONCOLOGY

Co-morbidity index predicts for mortality after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer

(2009) Neil Kopek et al.   RADIOTHERAPY AND ONCOLOGY

Once-Weekly, High-Dose Stereotactic Body Radiotherapy for Lung Cancer: 6-Year Analysis of 60 Early-Stage, 42 Locally Advanced, and 7 Metastatic Lung Cancers

(2008) Omar M. Salazar et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Baseline Pulmonary Function as a Predictor for Survival and Decline in Pulmonary Function Over Time in Patients Undergoing Stereotactic Body Radiotherapy for the Treatment of Stage I Non–Small-Cell Lung Cancer

(2008) Mark Henderson et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study

(2008) Pia Baumann et al.   RADIOTHERAPY AND ONCOLOGY

Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning

(2007) Peter Fritz et al.   LUNG CANCER